Skip to Content
Merck
All Photos(1)

Documents

T9039

Sigma-Aldrich

Tris Buffered Saline, with Tween™ 20, pH 8.0

powder, pH 8.0, with Tween® 20

Synonym(s):

TBS, TBST

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41105319
NACRES:
NA.25

product name

Tris Buffered Saline, with Tween™ 20, pH 8.0, powder

form

powder

Quality Level

Looking for similar products? Visit Product Comparison Guide

Application

Tris Buffered Saline, with Tween® 20, pH 8.0 has been used as a wash buffer in western blotting and enzyme linked immunosorbent assay. It has also been used along with 5% milk to block proteins on nitrocellulose in western blotting.

Biochem/physiol Actions

Tris Buffered Saline with Tween 20 is predominantly used as a wash buffer and also in blocking steps of immunoblotting technique.

Packaging

Foil pouches

Reconstitution

Contents of one pouch, when dissolved in one liter of distilled or deionized water, will yield 0.05 M Tris buffered saline (NaCl - 0.138 M; KCl - 0.0027 M); TWEEN® 20 - 0.05%, pH 8.0, at 25 °C.

Legal Information

TWEEN is a registered trademark of Croda International PLC

related product

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Are camel milk proteins convenient to the nutrition of cow milk allergic children?
El-Agamy EI, et al.
Small Ruminant Research, 82(1), 1-6 (2009)
Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer
Guy MS, et al.
Gynecologic Oncology, 140(3), 518-526 (2016)
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer
Ye Leiguang, et al.
FEBS Open Bio, 5(1), 809-812 (2015)
Joey P Ting et al.
PloS one, 13(1), e0190850-e0190850 (2018-01-13)
To date, IL-17A antibodies remain the only therapeutic approach to correct the abnormal activation of the IL-17A/IL-17R signaling complex. Why is it that despite the remarkable success of IL-17 antibodies, there is no small molecule antagonist of IL-17A in the
Differential antibody responses to gliadin-derived indigestible peptides in patients with schizophrenia
McLean RT, et al.
Translational Psychiatry, 7(5), e1121-e1121 (2017)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service